| 发明名称 |
MMP2 AS A PREDICTIVE BIOMARKER OF RESPONSE TO ANTIANGIOGENIC THERAPY AND SURVIVAL AFTER THERAPY IN CANCER PATIENTS |
| 摘要 |
<p>The present invention relates to the use of matrix metalloproteinase-2 (MMP2) as a predictive biomarker of response to antiangiogenic therapy and survival after antiangiogenic therapy in cancer patients, and to a related methods for predicting or monitoring the response to an antiangiogenic treatment and the survival after said treatment of a cancer patient.</p> |
| 申请公布号 |
EP2852842(A1) |
申请公布日期 |
2015.04.01 |
| 申请号 |
EP20130735437 |
申请日期 |
2013.05.23 |
| 申请人 |
UNIVERSITE D'AIX MARSEILLE;ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE |
发明人 |
CHINOT, OLIVIER;TABOURET, EMELINE |
| 分类号 |
G01N33/574 |
主分类号 |
G01N33/574 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
